Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Canadian Government Invests Millions in Stem Cell Research Projects

XTALKS VITALS NEWS

Money

This funding will be used to support 31 projects and clinical trials being conducted across Canada.

Share this!

November 29, 2016 | by Sarah Hand, M.Sc.

Canadian stem cell researchers are about to benefit from a $12 million infusion of government funding. Stem cells have the potential to treat patients with a number of chronic diseases, such as spinal cord injuries, diabetes, Alzheimer’s disease and arthritis.

“For years, Canadian researchers have been leaders in regenerative medicine,” said The Honourable Kirsty Duncan, Minister of Science for the Government of Canada. “The funding announced today will support projects that encourage important partnerships between universities, hospitals and businesses so they may collaborate on bold, new stem cell technologies and health innovations that will improve the lives of Canadians. I am confident that, through the Stem Cell Network, Canadians are gaining a better understanding of this promising research, the results of which contribute to a strong and healthy population.”



Duncan announced that $9 million would be used to fund research projects and clinical trials through the Stem Cell Network (SCN). This is part of the $12 million in funding for stem cell research allocated in the Government of Canada’s 2016 budget.

Stem cell therapies have the potential to treat – and potentially prevent – numerous diseases. Regenerative medicine is already in use the field of oncology, where stem cells are used to treat blood cancers such as leukemia.

“We are a nation of leaders and innovators; it is in our DNA,” said Dr. Michael Rudnicki, Scientific Director and CEO, Stem Cell Network. “The regenerative medicine research sector is fueled by stem cells and today it is at a tipping point, with the potential to see breakthroughs in our generation. I am thrilled that SCN is able to power the foundation of scientific excellence that exists within Canada's universities, research hospitals and institutes.”

This funding will be used to support 31 projects and clinical trials being conducted across Canada. The $12 million will benefit 106 stem cell researchers and around 200 trainees that are involved in regenerative medicine studies.


Keywords: Stem Cells, Regenerative Medicine, Clinical Trials


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News


Smartphone App Created Using Apple’s ResearchKit Used to Conduct Asthma Clinical Studies

March 22, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have conducted a large-scale, observational study of asthma patients using the Apple ResearchKit framework and the Asthma Health app on patients’ iPhones.

Featured In: Clinical Trials News


IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.